Wednesday, Nov 19, 2025 · SEC filings
What the smart money revealed on Nov 19
576 insider filings came in. We hid 122 planned (10b5-1) sellers and 241 people whose filings were routine, like grants and tax withholding.
3 insiders at CervoMed (CRVO) bought $253K of stock
Roles: CEO, CFO, Chief Commercial and Business. Several insiders buying in the same few days is rare.
Annexon (ANNX) Director Muneer Satter bought $5.05M
1.5M shares on the open market. Not a grant or an option exercise.
Alumis (ALMS) Director James Tananbaum bought $3.09M
507,874 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Alumis (ALMS) Director Srinivas Akkaraju bought $1.53M
241,338 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 7 checked quarters beat the typical stock 6 months later.
Keystone Private Income Fund President John Earl bought $1M
10,126 shares on the open market. Not a grant or an option exercise.
TheRealReal (REAL) Director Gilbert Baird sold $102M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Cadre (CDRE) CEO and Chairman Warren Kanders sold $52.4M
Not marked as a planned 10b5-1 sale. Sold 100% of the shares they held directly. Still holds 1,546 shares.
Circle Internet Group (CRCL) Director Rajeev Date sold $2.75M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 75 more real buys
Show 92 more real sales
13F season
Holdings as of Sep 30, 2025 were due Nov 14
81 funds have filed. 74 filed for the quarter before.
Biggest real insider buys, Nov 13–19
Open-market buys by officers and directors, filed in the 7 days up to Nov 19.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.